Keyphrases
Oral Bioavailability
100%
Myeloid Differentiation Factor 88 (MyD88)
100%
Bioactivity
100%
Cyclic Peptoids
100%
Myristoylation
100%
Cyclic Peptide
28%
Mouse Model
28%
Disease Severity
28%
Dimerization
28%
Multiple Sclerosis
28%
Metabolically Stable
28%
Orally Bioavailable
28%
Inflammatory Cytokines
14%
Inflammation
14%
Autoimmune Disease
14%
Autoimmunity
14%
Receptor Signaling
14%
Oral Administration
14%
Innate Immune Response
14%
Living Cells
14%
Toll-like
14%
Adaptor Protein
14%
Multiple Receptor
14%
Receptor 1
14%
IL-1 Receptor
14%
Active Regions
14%
Myelin Antigens
14%
Human Autoimmune Diseases
14%
Competitive Inhibitor
14%
Parenteral Administration
14%
N-terminal Myristoylation
14%
Autoimmune T Cells
14%
Competitive Inhibition
14%
Medicine and Dentistry
Biological Activity
100%
Myeloid Differentiation Factor 88
100%
Bioavailability
100%
Cyclopeptide
100%
Myristylation
100%
Autoimmune Disease
33%
Receptor
33%
Disease Severity
33%
Multiple Sclerosis
33%
Competitive Inhibition
33%
Autoimmunity
16%
Oral Drug Administration
16%
T Cell
16%
Amino Terminal Sequence
16%
Interleukin-1
16%
Inflammatory Cytokine
16%
Myelin
16%
Toll Like Receptor
16%
Myeloid Differentiation
16%
Immunity
16%
Adaptor Protein
16%
Parenteral Drug Administration
16%
Immunology and Microbiology
Biological Activity
100%
Myristylation
100%
Autoimmune Disease
66%
Mouse Model
66%
Multiple Sclerosis
66%
Dimerization
66%
Competitive Inhibition
66%
Amino Terminal Sequence
33%
T Cell
33%
Autoimmunity
33%
Interleukin-1
33%
Inflammatory Cytokine
33%
Toll-Like Receptor
33%
Myeloid Differentiation
33%
Immunity
33%
Myelin
33%
Neuroscience
Cyclic Peptide
100%
Myristoylation
100%
Multiple Sclerosis
66%
Autoimmune Disease
66%
Competitive Inhibition
66%
Receptor
66%
Amino Terminal Sequence
33%
T Cell
33%
Myelin
33%
Myeloid
33%
Toll-Like Receptor
33%
Adaptor Protein
33%